Clinical Trial Update: Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on everolimus, cetuximab, and capecitabine in metastatic pancreatic cancer (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cetuximab (cetuximab)
• Everolimus (everolimus)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED